首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1871511

2021-2031年北美人類微生物組市場報告：範圍、細分、動態和競爭分析

North America Human Microbiome Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年09月01日 | 出版商:

The Insight Partners | 英文 129 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計北美人類微生物組市場將大幅成長，到 2031 年將達到約 28.1182 億美元，高於 2023 年的 6.5489 億美元，2023 年至 2031 年的年複合成長率(CAGR) 為 20.0%。

執行摘要和市場分析

北美是表觀遺傳學和微生物組研究的領先地區，其中美國佔據最大的市場佔有率，其次是加拿大。該地區人類微生物組市場的成長受多種因素驅動，包括廣泛的研究計劃、生物技術資金的增加、消費者健康意識的提高，以及對益生菌和益生元在慢性病管理方面日益成長的需求。此外，該地區高度重視開發以微生物組為基礎的療法，相關會議數量不斷增加，以及當地主要企業的存在，所有這些因素都有望促進市場成長和收入提升。

市場區隔分析

北美人類微生物組市場可按類型、應用和疾病類型細分：

類型：市場分為產品和軟體/服務，其中產品在 2023 年佔據更大的市場佔有率。產品部分可再細分為益生菌和益生元。
應用領域：市場分為治療、診斷和研究三個部分，其中治療領域在 2023 年佔據了市場佔有率的主導地位。
疾病類型：市場分為肥胖症、糖尿病、自體免疫疾病、癌症、胃腸道 (GIT) 問題等類別，其中 GIT 議題在 2023 年將引領市場。

市場展望

政府的各項措施和支持計畫在人類微生物組市場的發展中發揮著至關重要的作用。大量的資金和撥款通常用於微生物組研究，這加速了新療法、設備和診斷方法的發展。例如，美國國立衛生研究院 (NIH) 已承諾在五年內投入 1.15 億美元，用於支持人類微生物組計劃，該計劃旨在增進對人類健康的了解，並改善疾病的預防、診斷和治療。此類資金促進了創新和商業化，尤其有利於微生物組領域的初創企業和中小企業 (SME)。此外，建立基於微生物組產品的監管框架可以簡化新療法的引入流程，確保其安全性和有效性，從而增強消費者信心並提高市場接受度。

國家概況

北美人類微生物組市場涵蓋美國、加拿大和墨西哥，其中美國在2023年佔據最大的市場佔有率。微生物組研究在生物技術領域的應用正在迅速擴展，並逐漸成為治療多種慢性疾病的重要手段。這促使私人投資增加，並推動了環境微生物組工程的發展。過去十年，美國在人類微生物組研究方面投資約10億美元，其中約20%的資金用於人類微生物組計畫（HMP）。 HMP於2007年啟動，旨在為人類微生物組研究創建必要的科研資源，從而為微生物組研究和療法開發做出重大貢獻。

第14章：附錄

簡介目錄圖表

Product Code: TIPRE00003319

The North American human microbiome market is projected to grow significantly, reaching approximately USD 2,811.82 million by 2031, up from USD 654.89 million in 2023, reflecting a compound annual growth rate (CAGR) of 20.0% from 2023 to 2031.

Executive Summary and Market Analysis

North America stands as the leading region for epigenetics and microbiome research, with the United States commanding the largest market share, followed by Canada. The growth of the human microbiome market in this region is driven by several factors, including extensive research initiatives, increased funding for biotechnology, heightened health awareness among consumers, and a growing demand for probiotics and prebiotics aimed at managing chronic diseases. Additionally, there is a strong emphasis on developing microbiome-based therapeutics, an increase in relevant conferences, and the presence of key local players, all of which are expected to enhance market growth and revenue generation.

Market Segmentation Analysis

The North American human microbiome market can be segmented by type, application, and disease type:

Type: The market is divided into products and software/services, with products holding a larger market share in 2023. The product segment is further categorized into probiotics and prebiotics.
Application: The market is segmented into therapeutics, diagnostics, and research, with therapeutics dominating the market share in 2023.
Disease Type: The market is classified into categories such as obesity, diabetes, autoimmune disorders, cancer, gastrointestinal (GIT) issues, and others, with GIT issues leading the market in 2023.

Market Outlook

Government initiatives and support programs play a crucial role in the growth of the human microbiome market. Substantial funding and grants are often allocated for microbiome research, which accelerates the development of new treatments, devices, and diagnostics. For example, the National Institutes of Health (NIH) has committed USD 115 million over five years to support the Human Microbiome Project, which aims to enhance understanding of human health and improve disease prevention, diagnosis, and treatment. Such funding fosters innovation and commercialization, particularly for startups and small-to-medium enterprises (SMEs) in the microbiome sector. Furthermore, the establishment of regulatory frameworks for microbiome-based products can streamline the introduction of new treatments, ensuring safety and efficacy, which in turn boosts consumer confidence and market acceptance.

Country Insights

The North American human microbiome market includes the United States, Canada, and Mexico, with the US holding the largest market share in 2023. The application of microbiome research is rapidly expanding within biotechnology, emerging as a vital therapeutic approach for various chronic diseases. This has led to increased private investment and advancements in environmental microbiome engineering. Over the past decade, the US has invested around USD 1 billion in human microbiome research, with approximately 20% of this funding directed towards the Human Microbiome Project (HMP). Launched in 2007, the HMP aims to create essential research resources for studying the human microbiome, resulting in significant contributions to microbiome research and therapy development.

Recent Developments

The demand for human microbiome therapeutics in the US is further fueled by product launches and regulatory approvals. For instance, in November 2022, Ferring Pharmaceuticals received FDA approval for REBYOTA, a first-in-class microbiota-based live biotherapeutic designed to prevent recurrent Clostridioides difficile infections in adults following antibiotic treatment.

Company Profiles

Key players in the human microbiome market include MaaT Pharma, Ferring Holdings SA, AOBiome Therapeutics Inc, Finch Therapeutics Group Inc, Seres Therapeutics Inc, Merck & Co Inc, Rebiotix, Inc., Yakult Honsha Co., Ltd., IFF Nutrition & Biosciences, and Synthetic Biologics, Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. North America Human Microbiome Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Human Microbiome Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Significant Investments by Key Market Players
- 5.1.2 Government Initiatives
5.2 Market Restraints
- 5.2.1 Challenges During Production of Microbiome
5.3 Market Opportunities
- 5.3.1 Robust Investment in Research and Development
5.4 Future Trends
- 5.4.1 Emergence of Precision Medicine
5.5 Impact of Drivers and Restraints:

6. North America Human Microbiome Market - Analysis

6.1 North America Human Microbiome Market Revenue (US$ Million), 2021-2031
6.2 North America Human Microbiome Market Forecast Analysis

7. North America Human Microbiome Market Analysis - by Type

7.1 Product
- 7.1.1 Overview
- 7.1.2 Product: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Software and Services
- 7.2.1 Overview
- 7.2.2 Software and Services: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Human Microbiome Market Analysis - by Application

8.1 Therapeutics
- 8.1.1 Overview
- 8.1.2 Therapeutics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diagnostics
- 8.2.1 Overview
- 8.2.2 Diagnostics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Research
- 8.3.1 Overview
- 8.3.2 Research: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Human Microbiome Market Analysis - by Disease Type

9.1 Obesity
- 9.1.1 Overview
- 9.1.2 Obesity: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Diabetes: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Autoimmune Disorder
- 9.3.1 Overview
- 9.3.2 Autoimmune Disorder: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Cancer
- 9.4.1 Overview
- 9.4.2 Cancer: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 GIT
- 9.5.1 Overview
- 9.5.2 GIT: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Human Microbiome Market - Country Analysis

10.1 North America
- 10.1.1 North America Human Microbiome Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 North America Human Microbiome Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United States: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 United States: North America Human Microbiome Market Share - by Type
    - 10.1.1.2.2 United States: North America Human Microbiome Market Share - by Product
    - 10.1.1.2.3 United States: North America Human Microbiome Market Share - by Application
    - 10.1.1.2.4 United States: North America Human Microbiome Market Share - by Disease Type
  - 10.1.1.3 Canada: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Canada: North America Human Microbiome Market Share - by Type
    - 10.1.1.3.2 Canada: North America Human Microbiome Market Share - by Product
    - 10.1.1.3.3 Canada: North America Human Microbiome Market Share - by Application
    - 10.1.1.3.4 Canada: North America Human Microbiome Market Share - by Disease Type
  - 10.1.1.4 Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Mexico: North America Human Microbiome Market Share - by Type
    - 10.1.1.4.2 Mexico: North America Human Microbiome Market Share - by Product
    - 10.1.1.4.3 Mexico: North America Human Microbiome Market Share - by Application
    - 10.1.1.4.4 Mexico: North America Human Microbiome Market Share - by Disease Type

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Human Microbiome Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Ferring Holdings SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 AOBiome Therapeutics Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Finch Therapeutics Group Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Financial Overview
- 13.4.4 SWOT Analysis
- 13.4.5 Key Developments
13.5 Seres Therapeutics Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck & Co Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Yakult Honsha Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Rebiotix, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 IFF Nutrition & Biosciences
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Synthetic Biologics, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 List of Abbreviations

簡介目錄圖表

List Of Tables

Table 1. North America Human Microbiome Market Segmentation
Table 2. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Type
Table 6. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 11. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 13. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 15. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 16. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 17. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 18. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 19. Recent Organic Growth Strategies in the Human Microbiome Market
Table 20. Recent Inorganic Growth Strategies in the Human Microbiome Market
Table 21. List of Abbreviations

List Of Figures

Figure 1. North America Human Microbiome Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. North America Human Microbiome Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Human Microbiome Market Revenue (US$ Million), 2021-2031
Figure 6. North America Human Microbiome Market Share (%) - by Type (2023 and 2031)
Figure 7. Product: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Software and Services: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. North America Human Microbiome Market Share (%) - by Application (2023 and 2031)
Figure 10. Therapeutics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Diagnostics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Research: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. North America Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
Figure 14. Obesity: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Diabetes: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Autoimmune Disorder: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Cancer: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. GIT: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. Others: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. North America Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 23. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 24. Heat Map Analysis by Key Players
Figure 25. Company Positioning and Concentration
Figure 26. Growth Strategies in the Human Microbiome Market